Related Experiment Video
Updated: Jan 4, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
Alessia Di Silvestre1, Marianna Lucafò2, Letizia Pugnetti1
1PhD School in Science of Reproduction and Development, University of Trieste, Trieste 34127, Italy.
Insights
Phosphorylated Tristetraprolin (TTP) binds to 14-3-3 protein, promoting inflammation in pediatric inflammatory bowel disease (IBD). This study found increased phospho-TTP/14-3-3 complex in IBD tissues and macrophages, correlating with higher TNF-α levels.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Inflammatory bowel disease (IBD) involves intestinal inflammation and epithelial injury, driven by excessive pro-inflammatory cytokine expression.
- Tristetraprolin (TTP) regulates inflammatory factors by binding cytokine mRNAs; its phosphorylation state dictates its mRNA-degrading activity.
- Phosphorylated TTP (phospho-TTP) forms a complex with 14-3-3, potentially exacerbating intestinal inflammation.
Purpose of the Study:
- To investigate the role of TTP phosphorylation in pediatric IBD.
- To determine if the phospho-TTP/14-3-3 complex is associated with IBD pathogenesis in children.
Main Methods:
- Analysis of inflamed and non-inflamed colonic mucosa from pediatric IBD patients.
- Experiments on macrophages differentiated from IBD patients' blood, with healthy donors as controls.
- Co-immunoprecipitation and immunoblotting to detect phospho-TTP/14-3-3 complex formation.
- Evaluation of TNF-α expression as a key pro-inflammatory marker.
Main Results:
- Elevated expression of TTP and the phospho-TTP/14-3-3 complex was observed in inflamed IBD colonic mucosa compared to non-inflamed samples.
- IBD-derived macrophages showed significantly higher levels of TTP and the phospho-TTP/14-3-3 complex than those from healthy controls.
- Increased TNF-α expression was detected in both inflamed IBD tissues and IBD-derived macrophages.
Conclusions:
- This study establishes a novel association between the phospho-TTP/14-3-3 complex and pediatric IBD.
- Higher levels of the phospho-TTP/14-3-3 complex in IBD samples suggest its contribution to disease progression.
- The findings highlight the potential of targeting the TTP/14-3-3 interaction in IBD treatment.
Background:
Intestinal inflammation and epithelial injury are the leading actors of inflammatory bowel disease (IBD), causing an excessive pro-inflammatory cytokines expression. Tristetraprolin (TTP), an mRNA binding protein, plays a role in regulating the inflammatory factors, recognizing specific sequences on the 3' untranslated region of cytokine mRNAs. TTP activity depends on its phosphorylation state: the unphosphorylated TTP degrades pro-inflammatory cytokine mRNAs; on the contrary, the phosphorylated TTP fails to destabilize mRNAs furthering their expression. The phospho-TTP forms a complex with the chaperone protein 14-3-3. This binding could be one of the factors that promote intestinal inflammation as a cause of disease progression.
Aim:
To assess if TTP phosphorylation has a role in paediatric IBD.
Methods:
The study was carried out on a cohort of paediatric IBD patients. For each patient enrolled, a specimen of inflamed and non-inflamed colonic mucosa was collected. Furthermore, the experiments were conducted on macrophages differentiated from blood samples of the same patients. Macrophages from healthy donors' blood were used as controls. Co-immunoprecipitation assay and immunoblotting analyses were performed to observe the formation of the phospho-TTP/14-3-3 complex. In the same samples TNF-α expression was also evaluated as major factor of the pro-inflammatory activity.
Results:
In this work we studied indirectly the phosphorylation of TTP through the binding with the chaperone protein 14-3-3. In inflamed and non-inflamed colon mucosa of IBD paediatric patients immunoblot assay demonstrated a higher expression of the TTP in inflamed samples respect to the non-inflamed; the co-immunoprecipitated 14-3-3 protein showed the same trend of expression. In the TNF-α gene expression analysis higher levels of the cytokine in inflamed tissues compared to controls were evident. The same experiments were conducted on macrophages from IBD paediatric patients and healthy controls. The immunoblot results demonstrated a high expression of both TTP and co-immunoprecipitated 14-4-3 protein in IBD-derived macrophages in comparison to healthy donors. TNF-α protein levels from macrophages lysates showed the same trend of expression in favour of IBD paediatric patients compared to healthy controls.
Conclusion:
In this work, for the first time, we describe a relation between phospho-TTP/14-3-3 complex and IBD. Indeed, a higher expression of TTP/14-3-3 was recorded in IBD samples in comparison to controls.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

